64
Views
30
CrossRef citations to date
0
Altmetric
Research Article

Combined ethinylestradiol/gestodene contraceptive patch: two-center, open-label study of ovulation inhibition, acceptability and safety over two cycles in female volunteers

, , , &
Pages 173-181 | Published online: 06 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Bettina Böttcher & Ludwig Wildt. (2014) New and emerging contraceptive options: a focus on transdermal contraception. Open Access Journal of Contraception 5, pages 1-5.
Read now
Luis Bahamondes & M Valeria Bahamondes. (2014) New and emerging contraceptives: a state-of-the-art review. International Journal of Women's Health 6, pages 221-234.
Read now
Rose Milanes-Skopp & Anita L Nelson. (2009) Transdermal contraceptive patches: current status and future potential. Expert Review of Clinical Pharmacology 2:6, pages 601-607.
Read now
Caroline L Strasinger, Nicole N Scheff & Audra L Stinchcomb. (2008) Prodrugs and codrugs as strategies for improving percutaneous absorption. Expert Review of Dermatology 3:2, pages 221-233.
Read now
C. Gerlinger, J. Endrikat, G. Kallischnigg & J. Wessel. (2007) Evaluation of menstrual bleeding patterns: a new proposal for a universal guideline based on the analysis of more than 4500 bleeding diaries. The European Journal of Contraception & Reproductive Health Care 12:3, pages 203-211.
Read now

Articles from other publishers (24)

Intira Sriprasert & David F. Archer. 2020. The Handbook of Contraception. The Handbook of Contraception 53 71 .
Donna Harrison, Cara Buskmiller, Monique Chireau, Lester A. Ruppersberger & Patrick P. YeungJr.Jr.. (2019) Systematic Review of Ovarian Activity and Potential for Embryo Formation and Loss during the Use of Hormonal Contraception. The Linacre Quarterly 85:4, pages 453-469.
Crossref
Stella D'Arpe, Mara Di Feliciantonio, Miriam Candelieri, Silvia Franceschetti, Maria Grazia Piccioni & Carlo Bastianelli. (2016) Ovarian function during hormonal contraception assessed by endocrine and sonographic markers: a systematic review. Reproductive BioMedicine Online 33:4, pages 436-448.
Crossref
Intira Sriprasert & David F. Archer. 2016. The Handbook of Contraception. The Handbook of Contraception 87 105 .
Julia Winkler, Mark Goldammer, Matthias Ludwig, Beate Rohde & Christian Zurth. (2014) Pharmacokinetic drug?drug interaction between ethinyl estradiol and gestodene, administered as a transdermal fertility control patch, and two CYP3A4 inhibitors and a CYP3A4 substrate. European Journal of Drug Metabolism and Pharmacokinetics 40:4, pages 389-399.
Crossref
Kumiyo Inoue, Alexandra Barratt & Juliet Richters. (2015) Does research into contraceptive method discontinuation address women's own reasons? A critical review. Journal of Family Planning and Reproductive Health Care 41:4, pages 292-299.
Crossref
Christian Zurth, Barbara Schuett, Manuela Casjens, Matthias Ludwig & Katrin Waellnitz. (2015) Pharmacokinetics and adhesion of a transdermal patch containing ethinyl estradiol and gestodene under conditions of heat, humidity, and exercise: A single-center, open-label, randomized, crossover study. Clinical Pharmacology in Drug Development 4:4, pages 245-255.
Crossref
M. Merz, R. Kroll, R. Lynen & K. Bangerter. (2015) Bleeding pattern and cycle control of a low-dose transdermal contraceptive patch compared with a combined oral contraceptive: a randomized study. Contraception 91:2, pages 113-120.
Crossref
D. Gruber, A. Sk?iv?nek, M. Serrani, V. Lanius & M. Merz. (2015) A comparison of bleeding patterns and cycle control using two transdermal contraceptive systems: a multicenter, open-label, randomized study. Contraception 91:2, pages 105-112.
Crossref
Inka Wiegratz, Susana Bassol, Edith Weisberg, Uwe Mellinger & Martin Merz. (2014) Effect of a Low-Dose Contraceptive Patch on Efficacy, Bleeding Pattern, and Safety: A 1-Year, Multicenter, Open-Label, Uncontrolled Study. Reproductive Sciences 21:12, pages 1518-1525.
Crossref
PAMELA A. ROYER & KIRTLY P. JONES. (2014) Progestins for Contraception. Clinical Obstetrics & Gynecology 57:4, pages 644-658.
Crossref
Carolyn L. Westhoff, Isabel Reinecke, Keith Bangerter & Martin Merz. (2014) Impact of body mass index on suppression of follicular development and ovulation using a transdermal patch containing 0.55-mg ethinyl estradiol/2.1-mg gestodene: a multicenter, open-label, uncontrolled study over three treatment cycles. Contraception 90:3, pages 272-279.
Crossref
Martin Merz & Julia Grunert. (2014) Effects of an Ethinyl Estradiol/Gestodene Transdermal Contraceptive Patch on the Endometrium: A Single-Center, Uncontrolled Study. Women's Health 10:1, pages 37-43.
Crossref
Wolfgang Junge, Doris Heger-Mahn, Dietmar Trummer & Martin Merz. (2013) Investigation of the Hemostatic Effect of a Transdermal Patch Containing 0.55 mg Ethinyl Estradiol and 2.1 mg Gestodene Compared with a Monophasic Oral Contraceptive Containing 0.03 mg Ethinyl Estradiol and 0.15 mg Levonorgestrel: An Open-Label, Randomized, Crossover Study. Drugs in R&D 13:3, pages 223-233.
Crossref
Regine Sitruk-Ware, Anita Nath & Daniel R. MishellJr.Jr.. (2013) Contraception technology: past, present and future. Contraception 87:3, pages 319-330.
Crossref
Christine Klipping, Ingrid Duijkers, Ageeth Remmers, Thomas Faustmann, Christian Zurth, Stefan Klein & Barbara Schuett. (2013) Ovulation‐Inhibiting Effects of Dienogest in a Randomized, Dose‐Controlled Pharmacodynamic Trial of Healthy Women. The Journal of Clinical Pharmacology 52:11, pages 1704-1713.
Crossref
Christoph Gerlinger, Harald Siedentop, Oke Gerke, Ilka Schellschmidt & Jan Endrikat. (2012) Optimal dose de-escalation trial designs for novel contraceptives in women. Computational Statistics & Data Analysis 56:5, pages 1061-1068.
Crossref
Jeffrey T. Jensen. (2011) The future of contraception: innovations in contraceptive agents: tomorrow's hormonal contraceptive agents and their clinical implications. American Journal of Obstetrics and Gynecology 205:4, pages S21-S25.
Crossref
Anita L. Nelson. 2011. Contraception. Contraception 76 85 .
S Rowlands. (2009) New technologies in contraception. BJOG: An International Journal of Obstetrics & Gynaecology 116:2, pages 230-239.
Crossref
Iñaki Lete, Jose Luis Doval, Ezequiel Pérez-Campos, Rafael Sánchez-Borrego, Marta Correa, Esther de la Viuda, Mari Angeles Gómez, José Vicente González, Roberto Lertxundi, María Teresa Martínez, Nicolás Mendoza & Javier Robledo. (2007) Factors affecting women's selection of a combined hormonal contraceptive method: the TEAM-06 Spanish cross-sectional study. Contraception 76:2, pages 77-83.
Crossref
EFTHIMIOS DELIGEOROGLOU, PANAGIOTIS CHRISTOPOULOS & GEORGE CREATSAS. (2007) Contraception in Adolescence. Annals of the New York Academy of Sciences 1092:1, pages 78-90.
Crossref
GIUSEPPE BENAGIANO, CARLO BASTIANELLI & MANUELA FARRIS. (2007) Contraception Today. Annals of the New York Academy of Sciences 1092:1, pages 1-32.
Crossref
Senshang Lin & Yie W Chien. (2006) Transdermal Contraceptive Patches. American Journal of Drug Delivery 4:4, pages 201-213.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.